NCT00087100 Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer Status COMPLETED Phase PHASE2
NCT00085332 Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) Status COMPLETED Phase PHASE2
NCT00071929 Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer Status COMPLETED Phase PHASE2
NCT00053794 Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma Status COMPLETED Phase PHASE2
NCT00052312 Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer Status COMPLETED Phase PHASE2
NCT00033605 Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis Status COMPLETED Phase PHASE3
NCT00033358 Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer Status COMPLETED Phase PHASE2
NCT00032162 Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00030485 Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer Status COMPLETED Phase PHASE2
NCT00023894 Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer Status COMPLETED Phase PHASE2
NCT00022620 Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer Status COMPLETED Phase PHASE2
NCT00019331 Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors Status COMPLETED Phase PHASE2
NCT00016341 Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer Status TERMINATED Phase PHASE3
NCT00010829 Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors Status COMPLETED Phase PHASE2
NCT00006377 Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer Status COMPLETED Phase PHASE2
NCT00006357 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Status COMPLETED Phase PHASE1/PHASE2
NCT00006027 Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer Status COMPLETED Phase PHASE3
NCT00005861 Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer Status COMPLETED Phase PHASE2